Cilostazol for intermittent claudication-Reference-Cited by-同舟云学术

Cilostazol for intermittent claudication

Published:2014-10-31 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Bedenis Rachel¹,Stewart Marlene¹,Cleanthis Marcus²,Robless Peter³,Mikhailidis Dimitri P⁴,Stansby Gerard⁵

Affiliation:

1. University of Edinburgh; Centre for Population Health Sciences; Edinburgh UK EH8 9AG

2. Frimley Park Hospital NHS Foundation Trust; Surrey UK GU16 7UJ

3. National University Health System; Department of Cardiac, Thoracic and Vascular Surgery; 5 Lower Kent Ridge Road Singapore Singapore 119074

4. Royal Free Hospital Campus, University College London Medical School; Department of Clinical Biochemistry; University College London (UCL) Pond Street London UK NW3 2QG

5. Freeman Hospital; Northern Vascular Centre; Newcastle upon Tyne UK NE7 7DN

Publisher

Wiley

Subject

Pharmacology (medical)

Reference69 articles.

1. A new pharmacological treatment for intermittent claudication: results of a randomized, multicenter trial;Beebe;Archives of Internal Medicine,1999

2. Otsuka America Pletal (Cilostazol) Tablets. Study 21-92-202 www.accessdata.fda.gov/drugsatfda_docs/nda/99/20863.cfm (accessed May 2014)

3. A phase II dose-ranging study of the phosphodiesterase inhibitor K-134 in patients with peripheral artery disease and claudication;Brass;Journal of Vascular Surgery,2012

4. Application of adaptive design and decision making to a phase II trial of a phosphodiesterase inhibitor for the treatment of intermittent claudication;Lewis;Trials,2011

5. NCT00783081 Safety and efficacy of K-134 for the treatment of intermittent claudication www.clinicaltrials.gov/ct2/show/NCT00783081 (accessed May 2014)

Cited by 144 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Transcriptome- and proteome-wide Mendelian randomization to prioritize therapeutic targets for coronary heart disease;2024-06-28

2. 2024 ACC/AHA/AACVPR/APMA/ABC/SCAI/SVM/SVN/SVS/SIR/VESS Guideline for the Management of Lower Extremity Peripheral Artery Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines;Circulation;2024-06-11

3. Overview and comparison of contemporary Society for Vascular Surgery, American Heart Association/American College of Cardiology, and European Society for Vascular Surgery guidelines for the management of patients with intermittent claudication;Seminars in Vascular Surgery;2024-06

4. 2024 ACC/AHA/AACVPR/APMA/ABC/SCAI/SVM/SVN/SVS/SIR/VESS Guideline for the Management of Lower Extremity Peripheral Artery Disease;Journal of the American College of Cardiology;2024-06

5. Effects of additional exercise therapy after a successful vascular intervention for people with symptomatic peripheral arterial disease;Cochrane Database of Systematic Reviews;2024-05-02